C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2761248
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Dystrophin family, in particular, by targeting natural antisense polynucleotides of Dystrophin family. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of DMD family.
La présente invention concerne des antinucléotides antisens qui modulent l'expression et/ou la fonction de la famille de la dystrophine, en particulier, par ciblage de polynucléotides antisens naturels de la famille de la dystrophine. L'invention concerne également l'identification desdits oligonucléotides antisens ainsi que leur utilisation dans le traitement de maladies et troubles associés à l'expression de la famille de la DMD.
Collard Joseph
Khorkova Sherman Olga
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
Opko Curna Llc
LandOfFree
Treatment of dystrophin family related diseases by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of dystrophin family related diseases by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of dystrophin family related diseases by... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499838